NCT00001499
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +10 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
518 public trials
102 recruiting studies
Carcinoma trial results
NCT00075166
- Conditions
- Brain Diseases, Brain Neoplasms, Carcinoma, +21 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00071357
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +6 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00071383
- Conditions
- Brain Diseases, Brain Neoplasms, Breast Diseases, +12 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
Completed
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck
NCT00195299
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
- Locations
-
- Shreveport, Louisiana, United States
NCT00034346
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +16 more
- Locations
-
Not specified
NCT00388063
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
- Locations
-
- Hematology Oncology Services of Arkansas Little Rock, Arkansas, United States
- Cedars Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center of Northwestern Chicago, Illinois, United States
NCT00191763
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Istanbul, Turkey (Türkiye)
Completed
Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder
NCT00343356
- Conditions
- Bladder Neoplasms, Carcinoma, Female Urogenital Diseases, +12 more
- Locations
-
Not specified
NCT00301548
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +6 more
- Locations
-
Not specified